Aurobindo Pharma has received US FDA's final approval for Clindamycin Hydrochloride capsules USP 150mg (base) and 300mg. Similarly, Swissmedic, Government of Switzerland has approved the license of Cefepime APL for Injection 1g and 2g.
The details can be read here.
No comments:
Post a Comment